Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujin Hoshida

Showing results (151-160 of 263) with videos related to

Pageof 27
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 11, 2024
Cell Segmentation With Globally Optimized Boundaries (CSGO): A Deep Learning Pipeline for Whole-Cell Segmentation in Hematoxylin-and-Eosin-Stained TissuesZifan Gu, Shidan Wang, Ruichen Rong, et al.
European Radiology|February 23, 2020
MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinomaStefanie J Hectors, Sara Lewis, Cecilia Besa, et al.
Hepatology Communications|June 17, 2022
Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signatureMyung-Ho Kim, Mi-Young Kim, Shadi Salloum, et al.
Journal of Hepatology|March 9, 2010
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockageVictoria Tovar, Clara Alsinet, Augusto Villanueva, et al.
Scientific Reports|December 21, 2016
The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through AutophagyRosa S Kim, Daisuke Hasegawa, Nicolas Goossens, et al.
Gastro Hep Advances|August 12, 2024
Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention StrategyKenneth K Tanabe, David Zahrieh, Carrie A Strand, et al.
Gut|June 6, 2015
A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resectionDavid Y Zhang, Nicolas Goossens, Jinsheng Guo, et al.
Hepatology (Baltimore, Md.)|September 22, 2005
Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis CNaoya Kato, Guijin Ji, Yue Wang, et al.
The American Journal of Surgical Pathology|July 4, 2020
Steatohepatitic Variant of Hepatocellular Carcinoma Is Associated With Both Alcoholic Steatohepatitis and Nonalcoholic Steatohepatitis: A Study of 2 Cohorts With Molecular InsightsJia Qin, Takaaki Higashi, Shigeki Nakagawa, et al.
Gut|November 17, 2016
Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinomaJulien Bollard, Verónica Miguela, Marina Ruiz de Galarreta, et al.
Pageof 27

Showing results (151-160 of 263) with videos related to

Sort By:
Pageof 27
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 11, 2024
Cell Segmentation With Globally Optimized Boundaries (CSGO): A Deep Learning Pipeline for Whole-Cell Segmentation in Hematoxylin-and-Eosin-Stained TissuesZifan Gu, Shidan Wang, Ruichen Rong, et al.
European Radiology|February 23, 2020
MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinomaStefanie J Hectors, Sara Lewis, Cecilia Besa, et al.
Hepatology Communications|June 17, 2022
Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signatureMyung-Ho Kim, Mi-Young Kim, Shadi Salloum, et al.
Journal of Hepatology|March 9, 2010
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockageVictoria Tovar, Clara Alsinet, Augusto Villanueva, et al.
Scientific Reports|December 21, 2016
The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through AutophagyRosa S Kim, Daisuke Hasegawa, Nicolas Goossens, et al.
Gastro Hep Advances|August 12, 2024
Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention StrategyKenneth K Tanabe, David Zahrieh, Carrie A Strand, et al.
Gut|June 6, 2015
A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resectionDavid Y Zhang, Nicolas Goossens, Jinsheng Guo, et al.
Hepatology (Baltimore, Md.)|September 22, 2005
Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis CNaoya Kato, Guijin Ji, Yue Wang, et al.
The American Journal of Surgical Pathology|July 4, 2020
Steatohepatitic Variant of Hepatocellular Carcinoma Is Associated With Both Alcoholic Steatohepatitis and Nonalcoholic Steatohepatitis: A Study of 2 Cohorts With Molecular InsightsJia Qin, Takaaki Higashi, Shigeki Nakagawa, et al.
Gut|November 17, 2016
Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinomaJulien Bollard, Verónica Miguela, Marina Ruiz de Galarreta, et al.
Pageof 27